Genetic, Genomic Testing to Play Key Role in Quest Diagnostics' Growth Efforts | GenomeWeb

NEW YORK (GenomeWeb News) – Quest Diagnostics held its first-ever Investor Day last Friday in New York providing a highly detailed view of its refocused strategy aimed at gaining share in the diagnostic testing market and its plans to revive flagging revenues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.